AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo
- 1 January 2015
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 73, 150-162
- https://doi.org/10.1016/j.nbd.2014.09.013
Abstract
No abstract availableKeywords
Funding Information
- Michael J. Fox Foundation
This publication has 47 references indexed in Scilit:
- Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell deathNeuropharmacology, 2014
- X‐ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neuronsJournal of Neurochemistry, 2012
- ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivoScientific Reports, 2012
- Axon degeneration in Parkinson's diseaseExperimental Neurology, 2012
- Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: Comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectorsJournal of Neuroscience Methods, 2010
- Rho-Associated Kinase II (ROCKII) Limits Axonal Growth after Trauma within the Adult Mouse Spinal CordJournal of Neuroscience, 2009
- Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted miceExperimental Neurology, 2007
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Dephosphorylation Targets Bcl-2 for Ubiquitin-dependent Degradation: A Link between the Apoptosome and the Proteasome PathwayThe Journal of Experimental Medicine, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998